Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $10.0600 (-4.19%) ($10.0400 - $10.0600) on Tue. Feb. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.62% (three month average) | RSI | 36 | Latest Price | $10.0600(-4.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 0.1% a day on average for past five trading days. | Weekly Trend | TGTX advances 0.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(77%) ARKG(72%) IBB(70%) ARKK(66%) IBUY(62%) | Factors Impacting TGTX price | TGTX will decline at least -4.31% in a week (0% probabilities). VIXM(-48%) VXX(-41%) UUP(-26%) TBT(-11%) USO(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.31% (StdDev 8.62%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $10.84 | 5 Day Moving Average | $10.72(-6.16%) | 10 Day Moving Average | $10.57(-4.82%) | 20 Day Moving Average | $10.84(-7.2%) | To recent high | -60% | To recent low | 18.7% | Market Cap | $1.274b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |